MAD Study of NX210c

Clinical trial NCT05827653 · COMPLETED

Trial details

NCT number: NCT05827653
Sponsor: Axoltis Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Elderly

Start date: 2022-12-05
Primary completion: 2023-04-29
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.